Bioluminescent plankton spotted at Cornwall beach
Mr Winstone happens to co-run a social media group dedicated to bioluminescent plankton, where people from across the UK come together to share sightings of the phenomenon."Seeing it in Cornwall was quite special," he said.
"Only by chance, when recomposing a photo, that I entered the water and at this point I saw the 'sparkles'," he added."We went to Kynance and initially shot from the cliff but whilst up there we could see the blue waves shining."He added: "I couldn't believe that by pure chance I found it in Cornwall."The trip was last minute when my mate messaged me to see if I wanted to head to the clear Cornish skies and try for the milkyway, knowing there is an active meteor shower and no moon it was all too good to be true."
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Independent
an hour ago
- The Independent
Experts reveal potential unintended side effect of Ozempic – and whether we should worry
The use of weight-loss jabs in the UK has skyrocketed, with an estimated 1.5 million people using them. Yet drugs like Ozempic and Wegovy don't just help people lose fat, but potentially muscle too, new research has suggested. A study that tested weight loss jabs on mice found that although muscle mass changes less than expected, muscles still get weaker and tissues like the liver also shrink. Weight-loss injections, also known as GLP-1 receptor agonists, work by mimicking the natural hormone which regulates blood sugar, appetite and digestion. The medications, known as semaglutides, predominantly treat diabetes but are also available on the NHS or via private providers to help adults with a high body mass index (BMI). For example, although Ozempic is used for type 2 diabetes, it is sometimes prescribed off-label as a weight-loss drug. The results of the study, published in the journal Cell Metabolism, revealed Ozempic -induced weight loss decreased muscle mass by about 10 per cent. Most of this lost weight wasn't from skeletal muscles, which surround bones and joints, but instead from other tissues like the liver, which shrank by nearly half. However, because the Ozempic was tested on mice, researchers emphasise that more research is needed to determine whether similar changes to organ size occur in humans and whether those changes come with any risks. 'Loss of mass in metabolically active organs, such as the liver, is expected as part of healthy weight loss,' said Dr Ran Hee Choi, research instructor in nutrition and integrative physiology at the University of Utah college of health, and co-first author on the study. In both mice and humans, weight gain and loss can affect the size of organs like the liver without affecting their function. 'It's unlikely that the observed lean mass loss represents a serious adverse effect,' added Dr Takuya Karasawa, another co-first author on the study. Researchers found some skeletal muscles did shrink by about 6 per cent as the mice lost weight, but not enough to explain the overall muscle loss. However, when someone gains fat, they also tend to gain skeletal muscle. Study authors explain this is because the body needs to work harder to move around. As a result, losing extra fat can lead to a loss of muscle, which will not affect the person's overall quality of life. Researchers also tested the amount of force the mice's muscles exerted and found that some muscle strength decreased as the mice lost weight, even when the size of the muscle stayed roughly the same. This potential loss of strength when taking Ozempic could be a particular concern for adults over the age of 60 who are at a higher risk of muscle loss and reduced mobility. 'The loss of physical function is a strong predictor of not just quality of life but longevity,' added Dr Katsu Funai, professor of nutrition at the University of Utah and the senior author on the study. Dr Funai concluded that further clinical trials of weight loss jabs should check for changes in muscle strength. A spokesperson for Novo Nordisk, which makes Ozempic, said: 'In clinical trial for Wegovy or Ozempic we did not specifically study the medicine's impact on muscle mass. In a sub-study of 140 patients with a BMI of 40 or less, analysis suggested that treatment with Wegovy was accompanied by reductions in both fat and lean body mass, with a greater reduction in fat mass than lean body mass. 'We recommend that any patients experiencing side effects while taking Wegovy or Ozempic contact their healthcare provider.'
The Independent
3 hours ago
- The Independent
New research changes what we know about dinosaur predators
A comprehensive new analysis of 18 dinosaur species has revealed that several of the giant prehistoric predators had weaker bites than previously assumed. Researchers, including those from the University of Bristol, found that Tyrannosaurus rex had skulls optimised for powerful, crushing bites, similar to modern crocodiles. In contrast, others such as spinosaurus and allosaurs possessed weaker bites, better suited for slashing and ripping flesh, akin to a Komodo dragon. The study, published in Current Biology, used 3D X-ray scanning technology to analyse skull mechanics and quantify bite strength across the species. This biomechanical diversity indicates that giant carnivorous dinosaurs followed different evolutionary paths, leading to a wider range of feeding strategies than often thought.
The Sun
6 hours ago
- The Sun
The 3 signs your toddler might be on the path to becoming a psychopath when they're older, according to a professor
A PROFESSOR has revealed the three signs that your toddler could be on the road to becoming a psychopath. New research shows that this personality disorder can in fact be detected in children, and the signs that parents should look out for. 2 Research reveals children can have these traits from a 'very young age' According to the studies conducted by Professor Essi Viding and her colleagues at University College London, you can detect behavioural traits that can increase a person's risk of developing psychopathy in children as young as three or four years old. The professor of developmental psychopathology told The Telegraph: "You do not get a full-blown personality disorder as a birthday present when you turn 18, so there are clearly children who have these sorts of traits from a very young age." She also emphasised that there is a difference between children who are badly behaved and those who exhibit what is known as conduct disorder with callous-unemotional (CU) traits. These traits are characterised by a lack of empathy and muted emotions. Professor Viding, 50, explained that you can identify children who are less affected by other people's sadness or who have a harder time regulating their emotions from as early as three years old. She added: "Of course, identifying these children early on doesn't mean you can definitively predict that someone will become an adult psychopath, but these are the children likely to be at an increased risk compared with their peers." She estimates that, among children, around one per cent of the wider population have the combination of conduct disorder with CU traits. The key signs to look out for Prof Viding identified three key areas where children with conduct disorder and associated CU traits are wired differently to others their age. The first is a lack of "emotional arousal" to another's upset or distress. She explained the scenario of your child taking another's toy. Frustrated mum Charlotte Cahill explains why parents are hold 24-hour sleep-out outside the Department of Education The typical response after being told off by their parent is for the child to feel bad, so they don't want to behave that way again, but this is not the reaction among children possessing psychopathic traits. The second is that the child struggled to make connections between doing something wrong and suffering the consequences. The third is that they don't get the same satisfaction from doing or saying things that make others happy, and instead, typically choose to put themselves first. Prof Viding added: "Children with high levels of CU traits don't seem to get the same reward out of pleasing others." Research on CU traits found in young children In her 25 years of experience, there is little she hasn't seen. Her previous studies and research has led Prof Viding to argue the case that no one is born a psychopath, but there are people whose genetic makeup puts them at higher risk than others of possessing such tendencies. The Telegraph also reported that researches at Cambridge University found that children whose hearts beat faster at the age of eight are at lower risk of developing adult psychopathy. However, it is not all bad news, as Prof Viding emphasised that treatment is effective and interventions can work. By adapting parenting styles, learning to how to help a child to regulate their reactions and emotions, and seeking ongoing professional help, you can prevent these traits from worsening. While treatment can significantly help, Prof Viding explained that unfortunately this is easier said than done. She described getting funding to help these children as an uphill battle. 2
